scispace - formally typeset
R

Ramachandran Rashmi

Researcher at Rajiv Gandhi Centre for Biotechnology

Publications -  7
Citations -  654

Ramachandran Rashmi is an academic researcher from Rajiv Gandhi Centre for Biotechnology. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 6, co-authored 6 publications receiving 626 citations.

Papers
More filters
Journal ArticleDOI

Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy

TL;DR: This review describes the mechanisms of curcumin-induced apoptosis currently known, and suggests several potential strategies that include down-regulation of antiapoptotic proteins by antisense oligonucleotides, use of proAPoptotic peptides and combination therapy, and other novel approaches against chemoresistant tumors.
Journal ArticleDOI

Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases.

TL;DR: In this paper, mild heat treatment induced the expression of heat shock protein-70 (hsp70), hsp90 and hsp27 in two human colon cancer cell lines, one derived from primary tumor, SW480, and the other derived from the secondary lymph node tissue, SW620, of the same patient.
Journal ArticleDOI

Caspase-2 Triggers Bax-Bak-dependent and -independent Cell Death in Colon Cancer Cells Treated with Resveratrol

TL;DR: The results from this study suggest that caspase-2 activation occurs upstream of mitochondria in resveratrol-treated cells, and the contribution of both Bax and Bak in mediating cell death induced by resver atrol and the existence of Bax/Bak-independent cell death possibly through casp enzyme-8- or caspasing-2-mediated mitochondria-independent downstream caspases.
Journal ArticleDOI

Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis

TL;DR: The present study demonstrates the potential of hsp70 in protecting SW480 cells from curcumin-induced apoptosis and highlights that silencing the expression of hSp70 is an effective approach to augment curcuming-based therapy in cancers that are resistant due to h Sp70 expression.
Journal ArticleDOI

Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL

TL;DR: The present study demonstrates the role of Bax but not Bak as a critical regulator of curcumin-induced apoptosis and implies the potential of targeting antiapoptotic proteins like Bcl-XL or overexpression of proapoptosis proteins like Smac as interventional approaches to deal with Bax-deficient chemo-resistant cancers for cur cumin-based therapy.